Romidepsin is a histone deacetylase (HDAC) inhibitor exhibiting anti-tumor activity. It targets HDAC1, HDAC2, HDAC4, and HDAC6. This compound is utilized in PROTAC development for its ability to inhibit HDACs and facilitate targeted protein degradation. Reagent grade, for research purpose.
Usually ships within 24 hours.